Swiss National Bank’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-522,900
Closed -$680K 2662
2022
Q4
$680K Buy
522,900
+15,300
+3% +$23.8K ﹤0.01% 2496
2022
Q3
$904K Hold
507,600
﹤0.01% 2388
2022
Q2
$1.15M Buy
507,600
+36,600
+8% +$87.6K ﹤0.01% 2286
2022
Q1
$1.55M Buy
471,000
+33,000
+8% +$116K ﹤0.01% 2179
2021
Q4
$1.99M Hold
438,000
﹤0.01% 2062
2021
Q3
$3.15M Buy
438,000
+23,400
+6% +$172K ﹤0.01% 1753
2021
Q2
$3.33M Buy
+414,600
New +$3.5M ﹤0.01% 1771

Other funds holding OCGN

Swiss National Bank's OCGN Position: Q1 2023 in Review

Swiss National Bank sold out of Ocugen (OCGN) in Q1 2023, closing a stake of 522,900 shares — an estimated $680K sold.

Swiss National Bank first reported a position in OCGN in Q2 2021 and held it in 7 quarters. The position peaked at $3.33M in Q2 2021. 103 funds tracked by Wall St. Rank hold OCGN as of Q1 2023.

  • Swiss National Bank reported no remaining Ocugen position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 522,900 Ocugen shares in Q1 2023, an estimated $680K.
  • Swiss National Bank first reported a position in Ocugen in Q2 2021 and held it in 7 quarters.
  • Swiss National Bank's Ocugen position peaked at $3.33M in Q2 2021.
  • 103 funds tracked by Wall St. Rank held Ocugen as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.